DaVita Inc. (DVA)
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
Improvement in RPT is likely to have boosted DaVita's top line in the third quarter.
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
DaVita HealthCare (DVA) concluded the recent trading session at $163.16, signifying a +1% move from its prior day's close.
DaVita HealthCare (DVA) Advances But Underperforms Market: Key Facts
In the most recent trading session, DaVita HealthCare (DVA) closed at $164.82, indicating a +0.15% shift from the previous trading day.
Can DaVita Stock Continue Its Bull Run After Doubling in a Year?
DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.
Here's Why You Should Add DaVita Stock to Your Portfolio Now
DVA's strength in its kidney care business raises optimism about the stock.
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
5 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run lately. Stocks like THC, SLVM, DVA, NCLH and IAG are seeing price strength, and the momentum is likely to continue.
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.
